PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company developing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and ...
“ PD-1 Non-Small Cell Lung Cancer Pipeline Insight, 2025 " report by DelveInsight outlines comprehensive insights into the ...
CAMBRIDGE, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today ...
WATERTOWN, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader ...
Oral presentation will highlight the results from the randomized Phase 3 trial (IOB-013/KN-D18) of IO102-IO103 cancer vaccine plus pembrolizumab for first-line (1L) advanced melanoma Poster ...
Company will provide an overview of the pritelivir clinical development program in two oral presentations including a comprehensive Phase 2 data overview Updated safety and pharmacokinetic results of ...
Eleven abstracts, including one oral presentation, feature new data across seven cancers Foundation Medicine, Inc., a precision medicine company transforming lives in cancer care and beyond, today ...
Second oral presentation will provide updated data from GDFATHER-01 trial demonstrating deep and durable remissions in heavily pretreated patients CatalYm, a world-leader in neutralizing GDF-15 in ...
Patients with chronic obstructive pulmonary disease (COPD) face a significant cardiovascular burden both before and after diagnosis. Analyses presented at the European Respiratory Society (ERS) ...
This is a preview. Log in through your library . Journal Information College Composition and Communication publishes research and scholarship in rhetoric and composition studies that supports college ...
ALIGARH, Sept. 21 -- Based Electrospun Nanofibers" at the International Conference on "Nanotechnology for Better Living (NBL-2025)," organized by the Department of Nanotechnology, University of ...